SARS-CoV II infection (Coronavirus disease) research hub

European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct)

This study is looking at a new treatment called Baricitinib for people admitted to hospital with COVID-19. It aims to see if it can stop people from getting sicker or dying, compared to a dummy treatment.